Strategic Advantages of the CRÉDIT D’IMPÔT RECHERCHE (CIR)
We are a specialized CDMO focused on Active Pharmaceutical Ingredients (APIs) and advanced intermediates. Consequently, we clearly understand the strategic importance of optimizing research resources. Thanks to this recent approval, our clients can obtain significant tax benefits. Furthermore, they gain competitive advantages by outsourcing their scientific projects to our facilities in Alhama de Murcia. This is especially true for companies operating within the French market.
In addition, our dedicated team of professionals constantly works on improving chemical synthesis routes. As a result, we ensure more efficient, scalable, and cost-effective processes. All this meticulous work is carried out while guaranteeing maximum regulatory compliance. Moreover, we always prioritize environmental safety in our daily operations. You can learn more about our integrated policies by visiting the Quality and EHS section of our website.
Driving the Future of Scientific Research
The granting of this important financial incentive is a great milestone. Specifically, it validates our analytical laboratories and production procedures. They meet the most demanding scientific excellence criteria at an international level. If you wish to obtain detailed institutional information, you can consult an official source. For instance, visit the website of the French Ministry of Higher Education and Research.
Relying on KINSY ensures a final product of the highest quality. Additionally, it facilitates a much more favorable financial environment for your research. Therefore, we cordially invite you to visit our Contact page. You can schedule a meeting with our experts easily. Finally, we will explore how we can be the ideal strategic partner for your future R&D challenges.
